1 asset in Tubulocystic Renal Cell Carcinoma
Therapeutic assets addressing Tubulocystic Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Pamiparib Tubulocystic Renal Cell Carcinoma | Jonsson Comprehensive Cancer Center | P2 | CCC (53) |